Potential therapeutic target for pulmonary arterial hypertension--osteopontin

Yasushi Hoshikawa, Yasushi Matsuda, Masahito Sakuma, Takashi Kondo

研究成果: Review article査読

2 被引用数 (Scopus)

抄録

Microarray analysis demonstrated lung gene encoding osteopontin (OPN), a soluble secreted phosphoprotein, was significantly elevated in rats with hypoxic pulmonary arterial hypertension (PAH). Since OPN enhances vascular smooth muscle cell proliferation, we hypothesized that OPN played a role in the pathogenesis of PAH. Some patients with idiopathic PAH showed increased expression of plasma OPN and lung OPN gene. OPN overexpression in mice caused pronounced pulmonary hypertension and vascular remodeling under hypoxic conditions. A PPARgamma ligand, pioglitazone, which was reported to inhibit OPN gene expression in vitro, attenuated hypoxia-induced increase in lung OPN gene and pulmonary vascular remodeling in rats. These findings indicate that OPN may be responsible for pulmonary vascular remodeling and could be a therapeutic target for PAH.

本文言語English
ページ(範囲)2097-2101
ページ数5
ジャーナルNippon rinsho. Japanese journal of clinical medicine
66
11
出版ステータスPublished - 11-2008
外部発表はい

All Science Journal Classification (ASJC) codes

  • Medicine(all)

フィンガープリント 「Potential therapeutic target for pulmonary arterial hypertension--osteopontin」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル